The relative importance of the usual diet in serum phospholipids in subjects with cystic fibrosis (CF) has been poorly studied. To compare the fatty acid profile in serum phospholipids from adult CF subjects with that of healthy subjects, and determine the role of the normal diet in this profile, we studied thirty-seven adult CF subjects with stable pulmonary disease and thirty-seven healthy controls matched for age, sex and nutritional status. A dietary questionnaire was obtained, anthropometric data were recorded, and the fatty acid profile measured by GLC. Compared with the controls, the percentages of myristic, palmitoleic and stearic acids and total MUFA were significantly higher in the CF group, and DHA, linoleic acid, total PUFA and n-6 fatty acids were significantly lower in the CF group. The CF subjects with worse pulmonary function and with pancreatic insufficiency had significantly lower levels of linoleic and n-6 fatty acids. The total energy intake was significantly higher in the CF subjects, although the energy distribution in the CF subjects and the controls was not different for the carbohydrates, lipids and proteins. No differences were detected in fat intake for MUFA (51 (SD 4) v. 52 (SD 4) %) or saturated fatty acids (33·5 (SD 5) v. 31·2 (SD 3·8) %), but the PUFA were slightly lower in the CF subjects (15·4 (SD 4·5) v. 17·4 (SD 4·2) %; P¼ 0·02). The usual dietary intake of fatty acids by adult CF subjects does not appear to explain the difference in the fatty acid profile compared with controls. This suggests an abnormal fatty acid metabolism in CF subjects.
Individuals with cystic fibrosis (CF) often have abnormal levels of essential fatty acid (EFA) in serum, plasma and blood cell membranes, as well as in tissue biopsies (Christophe & Robberecht, 2001; Freedman et al. 2004) . Compared with the general population, the most important feature in CF subjects is the low level of linoleic acid and DHA and the relative increase in the percentage of monoenoic and eicosatrienoic fatty acids (Lepage et al. 2002; Freedman et al. 2004 ). This anomalous profile has been seen not only in CF subjects with poor fat absorption or who are malnourished, but also in CF subjects with exocrine pancreatic insufficiency with an adequate energy intake and with normal fat absorption (Roulet et al. 1997) , as well as in CF subjects with no exocrine pancreatic insufficiency and with a good nutritional status (Lai et al. 2000; Freedman et al. 2004) . Although not supported by some experimental animal models (Werner et al. 2004) , it has been suggested that these findings may be caused by an intrinsic defect in fatty acid metabolism, together with the CF transmembrane conductance regulator (CFTR) gene (Freedman et al. 2004) , and that the effect is more pronounced in CF subjects with more severe mutations (Strandvik et al. 2001) . Together with this defect there also appears to exist an accelerated metabolism of arachidonic acid, which could contribute to both low linoleic acid concentration and to the inflammation (Carlstedt-Duke et al. 1986; Christophe & Robberecht, 2001) . As serum phospholipids are rich in EFA and are in dynamic equilibrium with tissue phospholipids, the fraction of the different fatty acid in this serum lipid class is often used as a marker of the usual intake and to determine the EFA status.
The importance of the daily diet on plasma or serum phospholipid fatty acids in subjects with CF has been poorly studied. Several studies have examined just individual dietary aspects (Tomezsko et al. 1992; Kawchak et al. 1996; Mora et al. 1996; Anthony et al. 1998; White et al. 2004) or only laboratory variables (fatty acid profile) (Christophe et al. 1994; Lloyd-Still et al. 1996; Benabdeslam et al. 1998; Strandvik et al. 2001) . Most studies which have analysed the phospholipid profile and diet together have been undertaken in countries where the usual diet differs greatly from that of the Mediterranean region (Roulet et al. 1997; Lai et al. 2000; Lepage et al. 2002) , were within the context of nutritional intervention studies (Lepage et al. 2002; De Vizia et al. 2003) , included mainly children (Lai et al. 2000; Lepage et al. 2002) or adolescents (Roulet et al. 1997; De Vizia et al. 2003) , failed to analyse the type of dietary fat (Lai et al. 2000; Lepage et al. 2002) or even lacked a control group of healthy subjects (Lai et al. 2000) .
The aim of the present study was to compare the fatty acid profile in serum phospholipids from adult subjects with CF with that from healthy subjects, as well as the role of the normal Mediterranean diet in this fatty acid profile.
Material and methods
The present study included individuals meeting the diagnostic criteria for CF according to the Cystic Fibrosis Foundation (CFF) consensus statement (Cystic Fibrosis Foundation, 1997) , and who were being periodically followed up at the Adult Cystic Fibrosis Unit, Carlos Haya University Hospital, Malaga, Spain. All the CF subjects were older than 16 years of age, had completed puberty, and had been in a clinically stable condition for 3 months before the present study, during which time they had not been admitted to hospital, nor had they had any respiratory exacerbations or weight change greater than 3 % of their body weight. The CF subjects were informed about the aims of the study and gave their written consent. A control group was composed of the same number of healthy individuals, matched for sex, age and nutritional status, selected from the Pizarra nutritional study in the province of Malaga (Soriguer et al. 2002) .
A 7 d, a prospective dietary questionnaire was administered to all the subjects in their homes. An experienced dietitian provided detailed instructions to the participants about weighing and recording all the food consumed. The same dietitian reviewed the questionnaire with the subjects to resolve any ambiguities. The dietary data were entered into a personal computer equipped with a nutrient content software package with composition tables for Spanish food (Moreiras et al. 1992; Mataix, 1995) . The fat composition of the fish consumed was taken from the data of Soriguer et al. (1997) . The composition of any nutritional supplements taken was also included in the database.
Comparison of the energy intake of all CF subjects and controls with the estimated daily energy requirement was made with the equation proposed by the Sociedad Española de Nutrición Comunitaria (Arija et al. 2001 ). The energy intake of the CF subjects was also compared with the daily energy requirement as calculated by the CFF equation (Ramsey et al. 1992) .
Measurements were made in all CF subjects and controls of weight and height, to calculate the BMI, and the upper-arm circumference. At the end of the 7 d period, blood was drawn, and the serum was immediately separated and stored at 270 8C until the measurements were made. The fatty acid composition of the serum phospholipids was made by extraction of the serum fat with chloroform-methanol (2:1, v/v) and butylated hydroxytoluene (0·025 %), and phospholipid separation by TLC (200 £ 200 £ 1 mm plates of silica gel 60G; solvents were hexane -ether -acetic acid; 80 : 20 : 2, by vol.). Fatty acid methyl esters were formed by heating the extracted fat for 30 min with 0·61 M-H 2 SO 4 in anhydrous methanol. After extraction with hexane, the fatty acid methyl esters were analysed in a Hewlett-Packard chromatograph (HP 4890; Hewlett Packard, Wilmington, DE, USA), equipped with a flame ionisation detector and using a BPX75 fused-silica capillary column (SGE, Villebon, France) (Soriguer et al. 2003) .
During the course of a routine follow-up examination in the CF subjects, a blood test was done and measurements made of clotting, basic biochemical parameters (by an autoanalyser), albumin, and fat-soluble vitamins A, D and E. A 72 h stool sample was collected for the quantitative measurement of faecal fat and N by means of a spectrophotometric technique (near IR reflectance analysis) (Picarelli et al. 1995) . Three measurements of the skinfold thickness of the triceps were made by the same investigator using a Holtain-type caliper, and the mean of the three measurements was assigned. Percentiles were estimated from the reference values for the Spanish population (Alastrue et al. 1988) .
The CF subjects underwent simple and forced spirometry, according to the Spanish Society of Respiratory Diseases and Thoracic Surgery (Sanchis et al. 1989) , and measurements were made of the forced vital capacity (FVC) and the forced expiratory volume in 1 s (FEV1). The values were expressed as a percentage of the theoretical value for individuals of the same sex, age, weight and height in a reference population (Roca et al. 1982) .
The severity of CF was assessed with the Bhalla score (Bhalla et al. 1991) , based on computerised tomography of the chest and the clinical and radiological modified National Institutes of Health score (Sockrider et al. 1994) . CFTR genotypes were classified into two groups (mild or severe) according to the reported phenotypic effects of the published mutations and on the primary mechanism of defective CFTR according to the expected effect of their mutation on CFTR protein function (Welsh & Smith, 1993) . The presence of two severe mutations was considered to reflect a severe genotype and the coexistence of two mild mutations or one severe and one mild was considered to reflect a mild genotype. The CF subjects classified as having a severe genotype (n 18) had the following combinations: DF508/DF508 (n 7), G542X/G542X (n 4), DF508/G542X (n 3), DF508/N1303K (n 1), DF508/1717-1G-. A (n 1), DF508/Q890X (n 1) or DF508/2184insA (n 1). Data analysis was performed with SPSS for Windows, version 11.0 (SPSS Inc, Chicago, IL, USA). Results are expressed as mean values with standard deviations. For comparison between groups the two-tailed unpaired Mann-Whitney test was used for quantitative variables and the x 2 test for qualitative variables. The Spearman rank linear correlation coefficient was calculated to describe the interrelationships between two measurements. A P value of , 0·05 was regarded as significant.
Results
A total of thirty-seven CF subjects and thirty-seven controls were studied (fifteen men and twenty-two women in each group). Table 1 summarises the main clinical characteristics of the CF subjects. The system mainly involved at diagnosis of CF was digestive in seventeen (46 %) subjects (three had meconium ileus) and respiratory in 18 (49 %). In the other two subjects (5 %), CF was diagnosed from a family history. Pancreatic insufficiency was present in 70 % of the CF subjects; these received pancreatic enzyme replacement and fatsoluble vitamin supplementation, with median daily doses of 3000 mg vitamin A, 20 mg vitamin D, and 200 mg vitamin E. The dose supplementation was assessed on an individual basis according to plasma levels. Vitamin K was only prescribed for CF subjects with uncontrolled pancreatic insufficiency or who were receiving a long course of antibiotic therapy. The CF subjects without exocrine pancreatic insufficiency received supplementary vitamin E (200 mg/d). Seven CF subjects (19 %) had diabetes mellitus but only three required pharmacological therapy. Colonisation with Haemophilus influenzae had been detected in 59 %, Pseudomonas (aeruginosa or cepacia) in 75 % and Staphylococcus aureus in 81 %. All the CF subjects routinely received advice on maximising dietary energy, protein and fat intake. Only eleven (30 %) CF subjects consumed nutritional supplements, which provided an average of 20 % of the total energy (2628 (SD 1167) kJ (628 (SD 279) kcal)/d). No patient took supplements enriched with n-3 fatty acids. The CF subjects consumed a mean of 114 % of the estimated energy requirement according to the CFF equation; seven CF subjects consumed less than 90 %, four CF subjects consumed from 90 to 100 % and 26 CF subjects consumed over 100 % of the energy estimated by this equation. Table 2 summarises the clinical data and the results of the dietary survey of the CF subjects and the controls. There were no differences in age, sex or anthropometric measurements. In the CF subjects the total energy intake was significantly higher, both in absolute terms and after correcting for body weight. Nevertheless, the respective energy distribution in the CF subjects and the controls of carbohydrates (45·3 (SD 5·6) v. 45·6 (SD 4·6) %), lipids (39·2 (SD 5·3) v. 39·6 (SD 4·6) %) and proteins (15 (SD 2·8) v. 14·3 (SD 2·1) %) was not different. There were no differences in fat intake with regard to MUFA (51 (SD 4) v. 52 (SD 4) %), saturated fatty acids (33·5 (SD 5) v. 31·2 (SD 3·8) %) or n-3 fatty acids (1·2 (SD 0·4) v. 1·2 (SD 0·4) %), but there was a slightly lower intake of total PUFA (15·4 (SD 4·5) v. 17·4 (SD 4·2) %) and n-6 fatty acids (14·2 (SD 4) v. 16 (SD 4) %). Table 3 shows the fatty acid composition of the serum phospholipids in CF subjects and controls. The percentages of myristic, palmitoleic and stearic acids, and total MUFA were significantly higher in the CF subjects, and the percentages of DHA, linoleic, total PUFA, n-6 and very-long-chain n-3 fatty acids were significantly lower in the CF subjects, compared with the healthy controls. Table 4 summarises the main clinical characteristics and the profile of the fatty acid composition of serum phospholipids according to the presence or absence of pancreatic insufficiency, the degree of respiratory involvement, the presence of carbohydrate metabolism disorders, the CFTR genotype, the percentage intake compared with that estimated by the CFF equation and according to nutritional status. According to these characteristics, no significant differences were found in the CF subjects concerning the percentage of energy derived from the various macronutrients (data not shown), with the exception of the percentage from the n-3 fatty acids in the subjects with pancreatic insufficiency (1·34 (SD 0·4) %) compared with those without pancreatic insufficiency (1·05 (SD 0·2) %), the percentage of total energy from the proteins in the subjects with carbohydrate metabolism disorders and in those without carbohydrate metabolism disorders (16·8 (SD 2) % v. 14·3 (SD 3) %), and the severe genotypes (15·9 (SD 3) %) v. the mild genotypes (14·1 (SD 2) %).
The levels of n-6 fatty acids and linoleic fatty acid in the serum phospholipids were significantly lower in CF subjects with a FEV1 percentage lower than 50 % compared with CF subjects who had a higher FEV1 percentage. No significant differences were found in the fatty acid profile depending on the presence or otherwise of chronic colonisation by Pseudomona, Haemophilus or Staphylococcus aureus.
As expected, the dietary MUFA (expressed as a percentage of total energy intake) correlated positively in the controls with the percentage of MUFA in the serum phospholipids (r 0·376; P¼0·02) and oleic acid (r 0·356; P¼ 0·03). The intake of carbohydrates (expressed as a percentage of total energy intake) was inversely correlated with the percentage of monoenoic fatty acids (r 2 0·404; P¼0·013), oleic acid (r 20·36; P¼0·029), DHA (r 2 0·34; P¼0·041), EPA (r 20·34; P¼0·041) and very-long-chain n-3 (r 2 0·387; P¼0·018) in the serum phospholipids. In the CF subjects, the intake of saturated fatty acids (expressed as a percentage of total energy intake) correlated positively with the percentage of palmitic acid (r 0·34; P¼0·041), stearic acid (r 0·34; P¼0·042) and saturated fatty acids (r 0·34; P¼0·044) and inversely with the percentage of oleic acid (r 2 0·33; P¼0·049) and monoenoic fatty acids (r 2 0·36; P¼0·03) in the serum phospholipids. Conversely, no statistically significant correlation was found in the CF subjects between the other components of the diet and the fatty acid composition of the serum phospholipids.
Positive correlations were found in the CF subjects between the fatty acid profile in the serum phospholipids and various anthropometric, spirometric, clinical and radiological parameters. The percentage of linoleic acid in the serum phospholipids correlated positively with weight (r 0·42; P¼0·01), the brachial circumference (r 0·33; P¼0·05), FEV1 in ml (r 0·367; P¼0·026), FEV1 percentage (r 0·31; P¼0·05) and FVC (r 0·34; P¼0·037). The percentage of n-6 in the serum phospholipids correlated positively with weight (r 0·37; P¼0·025), brachial circumference (r 0·35; P¼0·043), FEV1 in ml (r 0·367; P¼0·025), FEV1 percentage (r 0·32; P¼0·049), FVC (r 0·35; P¼ 0·033), FVC percentage (r 0·31; P¼0·045) and the modified National Institutes of Health score (r 0·31; P¼0·027).
Faecal fat and N were used as biological markers to validate the data given by the CF subjects in their dietary questionnaire. Faecal N correlated significantly with the weight of faecal fat (r 0·86; P¼0·0001), total energy consumed (r 0·47; P¼0·01) and the intake by weight of carbohydrates (r 0·35; P¼0·05), lipids (r 0·5; P¼ 0·005) and proteins (r 0·43; P¼0·015). The weight of faecal fat correlated positively with total energy consumed (r 0·35; P¼0·04) and the intake by weight of lipids (r 0·36; P¼0·033) and proteins (r 0·42; P¼0·01).
Discussion
The results of the present study show that the serum phospholipid fatty acid profile in adult subjects with CF is clearly different from those of a control population. Despite these differences, no significant differences were detected between the diet of the CF subjects and the controls with respect to percentage intake of macronutrients. The fraction of the different serum phospholipid fatty acids is often used as a marker of the usual intake and to determine the EFA status. However, the total serum fatty acids or the fractions contained in the triacylglycerols are influenced by recent food intake (during the few hours before blood extraction), as well as by other factors.
In line with previous experimental (Freedman et al. 1999 ) and human (Strandvik et al. 2001; Freedman et al. 2004) studies, this abnormal profile, therefore, suggests an abnormal turnover of EFA, with an increased release of arachidonic acid, associated with the disease itself via the altered CFTR gene (Carlstedt-Duke et al. 1986 ). Blockade of the synthesis of DHA or an increased susceptibility to stimulation of cytoplasmic phospholipase A2 could also be involved. As well as changes in fatty acid metabolism, other possible explanations include defects in fatty acid uptake in the intestine or poor absorption of the micronutrients.
Decreased levels of linoleic acid and DHA in plasma, cell membranes and tissues have been found in human subjects (Benabdeslam et al. 1998; Strandvik et al. 2001; Lepage et al. 2002; Freedman et al. 2004) . Levels of arachidonic acid have proved more variable in different studies, including plasma or serum values which were either not significantly different from the controls (as occurred in the present study) (Strandvik et al. 2001; Lepage et al. 2002; Freedman et al. 2004) , or were slightly decreased (Lloyd-Still et al. 1996; Benabdeslam et al. 1998) or even increased in biopsy material (Freedman et al. 2004) . These variable results could be explained by an accelerated metabolism of arachidonic acid (Carlstedt-Duke et al. 1986; Christophe & Robberecht, 2001) .
Unlike a previous report (Strandvik et al. 2001) , only the levels of n-6 and linoleic acid in the serum phospholipids of the CF subjects were altered, in accordance with the clinical characteristics of the participants. The levels of n-6 and linoleic acid were significantly lower in the CF subjects with worse pulmonary function (lower FEV1 percentage) and with pancreatic insufficiency and, to a lesser extent (without reaching significance), in the CF subjects who had severe genotypes and who were malnourished. However, no significant changes in the values of the other fatty acids studied were test for qualitative variables (sex, pancreatic insufficiency)): *P, 0·05, ** P, 0·01, ***P, 0·001. † M-NIH, modified National Institutes of Health score (Sockrider et al. 1994) . ‡ Bhalla et al. (1991) .
seen in relation to pancreatic insufficiency, the degree of pulmonary involvement, carbohydrate metabolism disorders, energy consumed, nutritional status or even the genotype. The nutritional status of our CF subjects was generally good; only 19 % had a BMI below 18·5 kg/m 2 , and the nutritional parameters were normal in almost all the CF subjects. The concentrations of fatty acids in the serum phospholipids were not significantly different between the undernourished and the well-nourished CF subjects. This suggests that the abnormal phospholipid profile in the CF subjects was not due to poor fat absorption or malnutrition but rather that these findings are simply aggravating factors or epiphenomena which are usually present in the most severe cases of CF (Roulet et al. 1997; Lai et al. 2000; Strandvik et al. 2001; Freedman et al. 2004) .
The adherence by our CF subjects to nutritional recommendations was very good. The energy intake of the CF subjects was clearly superior to the controls. Although not all energy consumed is absorbed, the CF subjects consumed over 130 % of the energy recommended for the healthy Spanish population and a mean of 114 % of the energy estimated by the CFF equation, which adjusts for patients with increased energy expenditure and loss. This difference in compliance in comparison with previous studies in children (Tomezsko et al. 1992; Kawchak et al. 1996; Anthony et al. 1998 ) and adults (White et al. 2004 ) may be because the current recommendations for individuals with CF (fat-rich diet) are relatively easy to achieve in Spain, as in other Mediterranean countries (De Vizia et al. 2003) , since they form part of the daily dietary habits of individuals from this area. The usual dietary intake, both in CF subjects and in controls, is about 20 % of total energy in the form of MUFA (more than 50 % of total fat intake), mainly olive oil, poor in carbohydrates and slightly increased in proteins. These data are similar to those reported by others in Spain, both for the general population (García-Almeida et al. 2001; Sociedad Española de Nutrición Comunitaria, 2001 ) and for subjects with other chronic diseases in which diet is an essential element, as for instance diabetes (Diabetes and Nutrition Study Group of the Spanish Diabetes Association, 2004).
Correction of abnormalities in the plasma fatty acid composition in malnourished CF subjects has been reported when additional energy was provided (Parsons et al. 1988) . Nevertheless our data do not confirm this concept. In fact, the CF subjects who consumed more than 100 % of the energy estimated by the CFF equation (a mean of 143 % of the energy recommended for the healthy Spanish population) had levels of fatty acids in the serum phospholipids that were not significantly different to those of the CF subjects who consumed less than 100 %.
The intake of fish, which was not high, was not significantly different between the CF subjects and the controls. The mean consumption of n-3 fatty acids was just 1 g/d (approximately 1 % of the total dietary fatty acids). Nevertheless, modifying the fatty acid profile of serum phospholipids in CF subjects probably requires supplementing the usual diet with higher levels of n-3 fatty acids (Freedman et al. 1999; Beckles et al. 2003; De Vizia et al. 2003) and it may also be necessary to combine them with g-linolenic acid (Christophe & Robberecht, 2001 ). The scarce correlations in the dietary survey with the fatty acid composition of serum phospholipids in the CF subjects strengthens the suggestion that the abnormal profile is barely modified with the usual non-supplemented diet. In fact, the strong correlation found between data from the dietary questionnaire and the content in faecal fat and N validates the correct collection and analysis of the data in the dietary questionnaire.
In conclusion, the fatty acid profile in serum phospholipids from adult subjects with CF is clearly different from that of healthy subjects. This difference is not explained by diet, suggesting an abnormal fatty acid metabolism in subjects with CF. The present study opens the door for clinical trials to assess the effectiveness and possible adverse effects of dietary interventions aimed at obtaining a desirable EFA status.
